(Q38797105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

review article

1 reference

title

Cardiovascular safety outcomes of new antidiabetic therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Marlys H LeBras

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Sheri L Koshman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

8 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Health-System Pharmacy

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

970-976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

Economic costs of diabetes in the U.S. in 2012

19 March 2020

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Drug safety assessment in clinical trials: methodological challenges and opportunities

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

How to use a noninferiority trial: users' guides to the medical literature

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Antidiabetic treatment with gliptins: focus on cardiovascular effects and outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Sitagliptin and the risk of hospitalization for heart failure: a population-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP160279

31 March 2020

Identifiers

DOI

10.2146/AJHP160279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28483748%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference